{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:43:08Z","timestamp":1790671388102,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hereditary gelsolin (AGel) amyloidosis is an autosomal dominantly inherited systemic amyloidosis that manifests with the characteristic triad of progressive ophthalmological, neurological and dermatological signs and symptoms. The National Finnish Gelsolin Amyloidosis Registry (FIN-GAR) was founded in 2013 to collect clinical data on patients with AGel amyloidosis, including altogether approximately one third of the Finnish patients. We aim to deepen knowledge on the disease burden and life span of the patients using data from the updated FIN-GAR registry. We sent an updated questionnaire concerning the symptoms and signs, symptomatic treatments and subjective perception on disease progression to 240 members of the Finnish Amyloidosis Association (SAMY). We analyzed the lifespan of 478 patients using the relative survival (RS) framework.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The updated FIN-GAR registry includes 261 patients. Symptoms and signs corresponding to the classical triad of ophthalmological (dry eyes in 93%; corneal lattice amyloidosis in 89%), neurological (numbness, tingling and other paresthesias in 75%; facial paresis in 67%), and dermatological (drooping eyelids in 86%; cutis laxa in 84%) manifestations were highly prevalent. Cardiac arrhythmias were reported by 15% of the patients and 5% had a cardiac pacemaker installed. Proteinuria was reported by 13% and renal failure by 5% of the patients. A total of 65% of the patients had undergone a skin or soft tissue surgery, 26% carpal tunnel surgery and 24% at least unilateral cataract surgery. As regards life span, relative survival estimates exceeded 1 for males and females until the age group of 70\u201374\u2009years, for which it was 0.96.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>AGel amyloidosis causes a wide variety of ophthalmological, neurological, cutaneous, and oral symptoms that together with repeated surgeries cause a clinically significant disease burden. Severe renal and cardiac manifestations are rare as compared to other systemic amyloidoses, explaining in part the finding that AGel amyloidosis does not shorten the life span of the patients at least for the first 75\u2009years.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-1300-5","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T14:02:50Z","timestamp":1579269770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3774-3855","authenticated-orcid":false,"given":"Eeva-Kaisa","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuuli","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Kiuru-Enari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero T.","family":"Kivel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Atula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"issue":"4","key":"1300_CR1","first-page":"314","volume":"1","author":"J Meretoja","year":"1969","unstructured":"Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res. 1969;1(4):314\u201324.","journal-title":"Ann Clin Res"},{"key":"1300_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/B978-0-444-52902-2.00039-4","volume-title":"Peripheral nerve disorders, volume 115: handbook of clinical neurology","author":"S Kiuru-Enari","year":"2013","unstructured":"Kiuru-Enari S, Haltia M. Hereditary gelsolin amyloidosis. In: Said G, Krarup C, editors. Peripheral nerve disorders, volume 115: handbook of clinical neurology. Amsterdam: Elsevier; 2013. p. 659\u201381."},{"issue":"6","key":"1300_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/07853890.2015.1075063","volume":"47","author":"T Nikoskinen","year":"2015","unstructured":"Nikoskinen T, Schmidt E-K, Strbian D, Kiuru-Enari S, Atula S. Natural course of Finnish gelsolin amyloidosis. Ann Med. 2015;47(6):506\u201311.","journal-title":"Ann Med"},{"issue":"4","key":"1300_CR4","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0404.1992.tb05099.x","volume":"86","author":"S Kiuru","year":"1992","unstructured":"Kiuru S. Familial amyloidosis of the Finnish type (FAF). Acta Neurol Scand. 1992;86(4):346\u201353.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"1300_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF00225202","volume":"95","author":"RD Steiner","year":"1995","unstructured":"Steiner RD, Evans JP, Paunio T, Uemichi T, Benson MD. Asp187Asn mutation of gelsolin in an American kindred with familial amyloidosis, Finnish type (FAP IV). Hum Genet. 1995;95(3):327\u201330.","journal-title":"Hum Genet"},{"issue":"12","key":"1300_CR6","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/S0161-6420(83)34369-4","volume":"90","author":"JJ Purcell","year":"1983","unstructured":"Purcell JJ, Rodrigues M, Chishti MI, Riner RN, Dooley JM. Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome). Ophthalmology. 1983;90(12):1512\u20137.","journal-title":"Ophthalmology"},{"issue":"1","key":"1300_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/13506129809007291","volume":"5","author":"S Kiuru","year":"1998","unstructured":"Kiuru S. Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide. Amyloid. 1998;5(1):55\u201366.","journal-title":"Amyloid"},{"issue":"1","key":"1300_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/mus.20448","volume":"33","author":"N Chastan","year":"2006","unstructured":"Chastan N, Baert-Desurmont S, Saugier-Veber P, D\u00e9rumeaux G, Cabot A, Fr\u00e9bourg T, et al. Cardiac conduction alterations in a French family with amyloidosis of the Finnish type with the p. Asp187Tyr mutation in the GSN gene. Muscle Nerve. 2006;33(1):113\u20139.","journal-title":"Muscle Nerve"},{"key":"1300_CR9","volume-title":"Inherited systemic amyloidosis with lattice corneal dystrophy","author":"J Meretoja","year":"1973","unstructured":"Meretoja J. Inherited systemic amyloidosis with lattice corneal dystrophy. Vammalan Kirjapaino, Vammala: Academic dissertation. University of Helsinki; 1973."},{"issue":"3","key":"1300_CR10","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/0888-7543(92)90182-R","volume":"13","author":"A de la Chapelle","year":"1992","unstructured":"de la Chapelle A, Kere J, Sack G, Tolvanen R, Maury C. Familial amyloidosis, Finnish type: G654\u2192 a mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics. 1992;13(3):898\u2013901.","journal-title":"Genomics"},{"issue":"10","key":"1300_CR11","first-page":"3759","volume":"35","author":"T Kivel\u00e4","year":"1994","unstructured":"Kivel\u00e4 T, Tarkkanen A, Frangione B, Ghiso J, Haltia M. Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome. Invest Ophthalmol Vis Sci. 1994;35(10):3759\u201369.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"1300_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0955-0674(99)80012-X","volume":"11","author":"DJ Kwiatkowski","year":"1999","unstructured":"Kwiatkowski DJ. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol. 1999;11(1):103\u20138.","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"1300_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2174\/138920308786733912","volume":"9","author":"R Bucki","year":"2008","unstructured":"Bucki R, Levental I, Kulakowska A, Janmey PA. Plasma gelsolin: function, prognostic value, and potential therapeutic use. Curr Protein Pept Sci. 2008;9(6):541\u201351.","journal-title":"Curr Protein Pept Sci"},{"issue":"1\u20132","key":"1300_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0014-5793(97)00237-8","volume":"406","author":"T Paunio","year":"1997","unstructured":"Paunio T, Kangas H, Kiuru S, Palo J, Peltonen L, Syv\u00e4nen A-C. Tissue distribution and levels of gelsolin mRNA in normal individuals and patients with gelsolin-related amyloidosis. FEBS Lett. 1997;406(1\u20132):49\u201355.","journal-title":"FEBS Lett"},{"issue":"3","key":"1300_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ajmg.1320420321","volume":"42","author":"M Haltia","year":"1992","unstructured":"Haltia M, Levy E, Meretoja J, Fernandez-Madrid I, Koivunen O, Frangione B. Gelsolin gene mutation\u2014at codon 187\u2014in familial amyloidosis, Finnish: DNA-diagnostic assay. Am J Med Genet. 1992;42(3):357\u20139.","journal-title":"Am J Med Genet"},{"issue":"4","key":"1300_CR16","first-page":"565","volume":"42","author":"D Kwiatkowski","year":"1988","unstructured":"Kwiatkowski D, Westbrook C, Bruns G, Morton C. Localization of gelsolin proximal to ABL on chromosome 9. Am J Hum Genet. 1988;42(4):565\u201372.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1300_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3343\/alm.2016.36.3.259","volume":"36","author":"K-J Park","year":"2016","unstructured":"Park K-J, Park J-H, Park J-H, Cho EB, Kim BJ, Kim J-W. The first Korean family with hereditary gelsolin amyloidosis caused by p. D214Y mutation in the GSN gene. Ann Lab Med. 2016;36(3):259\u201362.","journal-title":"Ann Lab Med"},{"issue":"1\u20132","key":"1300_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000131963","volume":"138","author":"E Klaus","year":"1959","unstructured":"Klaus E, Freyberger E, Kavka G, Vodi\u010dka F. Famili\u00e4res Vorkommen von bulb\u00e4rparalytischer Form der amyotrophischen Lateralsklerose mit gittriger Hornhautdystrophie und Cutis hyperelastica bei drei Schwestern. Eur Neurol. 1959;138(1\u20132):79\u201397.","journal-title":"Eur Neurol"},{"issue":"2","key":"1300_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/ng1092-157","volume":"2","author":"A de la Chapelle","year":"1992","unstructured":"de la Chapelle A, Tolvanen R, Boysen G, Santavy J, Bleeker-Wagemakers L, Maury C, et al. Gelsolin\u2013derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nat Genet. 1992;2(2):157\u201360.","journal-title":"Nat Genet"},{"issue":"10","key":"1300_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0035-3787(06)75110-4","volume":"162","author":"F Cont\u00e9gal","year":"2006","unstructured":"Cont\u00e9gal F, Bidot S, Thauvin C, L\u00e9v\u00e8que L, Soichot P, Gras P, et al. Une amylose finlandaise chez une patiente fran\u00e7aise. Rev Neurol (Paris). 2006;162(10):997\u20131001.","journal-title":"Rev Neurol (Paris)"},{"issue":"11","key":"1300_CR21","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/jnnp.42.11.1020","volume":"42","author":"G Boysen","year":"1979","unstructured":"Boysen G, Galassi G, Kamieniecka Z, Schlaeger J, Trojaborg W. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. J Neurol Neurosurg Psychiatry. 1979;42(11):1020\u201330.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1300_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1590\/S0004-27492011000400012","volume":"74","author":"HP Solari","year":"2011","unstructured":"Solari HP, Ventura MP, Antecka E, Belfort R Jr, Burnier MN Jr. Danish type gelsolin-related amyloidosis in a Brazilian family: case reports. Arq Bras Oftalmol. 2011;74(4):286\u20138.","journal-title":"Arq Bras Oftalmol"},{"issue":"5","key":"1300_CR23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/mus.25550","volume":"56","author":"JB Caress","year":"2017","unstructured":"Caress JB, Johnson JO, Abramzon YA, Hawkins GA, Gibbs JR, Sullivan EA, et al. Exome sequencing establishes a gelsolin mutation as the cause of inherited bulbar-onset neuropathy. Muscle Nerve. 2017;56(5):1001\u20135.","journal-title":"Muscle Nerve"},{"issue":"2","key":"1300_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3109\/13506129.2014.891502","volume":"21","author":"YA Efebera","year":"2014","unstructured":"Efebera YA, Sturm A, Baack EC, Hofmeister CC, Satoskar A, Nadasdy T, et al. Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred. Amyloid. 2014;21(2):110\u20132.","journal-title":"Amyloid"},{"issue":"1","key":"1300_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1053\/j.ajkd.2012.07.016","volume":"61","author":"S Sethi","year":"2013","unstructured":"Sethi S, Theis JD, Quint P, Maierhofer W, Kurtin PJ, Dogan A, et al. Renal amyloidosis associated with a novel sequence variant of gelsolin. Am J Kidney Dis. 2013;61(1):161\u20136.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"1300_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1399-0004.1973.tb01140.x","volume":"4","author":"J Meretoja","year":"1973","unstructured":"Meretoja J. Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clin Genet. 1973;4(3):173\u201385.","journal-title":"Clin Genet"},{"issue":"5","key":"1300_CR27","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/07853890.2016.1177197","volume":"48","author":"Eeva-Kaisa Schmidt","year":"2016","unstructured":"Schmidt E-K, Atula S, Tanskanen M, Nikoskinen T, Notkola I-L, Kiuru-Enari S. Causes of death and life span in Finnish gelsolin amyloidosis. Ann Med. 2016;48(5):352\u20138.","journal-title":"Annals of Medicine"},{"issue":"4","key":"1300_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1755-3768.2009.01566.x","volume":"88","author":"A Laitinen","year":"2010","unstructured":"Laitinen A, Laatikainen L, H\u00e4rk\u00e4nen T, Koskinen S, Reunanen A, Aromaa A. Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: a nationwide population-based survey. Acta Ophthalmol. 2010;88(4):463\u201371.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"1300_CR29","first-page":"618","volume":"159","author":"J Winkelman","year":"1971","unstructured":"Winkelman J, Delleman J, Ansink B. Ein heredit\u00e4res Syndrom, bestehend aus peripherer Polyneuopatie, Hauver\u00e4nderungen und gittriger Dystrophie der Hornhaut. Klin Monatsbl Augenheilkd. 1971;159(5):618\u201323.","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"1","key":"1300_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000308469","volume":"165","author":"J Meretoja","year":"1972","unstructured":"Meretoja J. Comparative histopathological and clinical findings in eyes with lattice corneal dystrophy of two different types. Ophthalmologica. 1972;165(1):15\u201337.","journal-title":"Ophthalmologica"},{"issue":"8","key":"1300_CR31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0161-6420(91)32153-5","volume":"98","author":"T Starck","year":"1991","unstructured":"Starck T, Kenyon KR, Hanninen LA, Beyer-Machule C, Fabian R, Gorn RA, et al. Clinical and histopathologic studies of two families with lattice corneal dystrophy and familial systemic amyloidosis (Meretoja syndrome). Ophthalmology. 1991;98(8):1197\u2013206.","journal-title":"Ophthalmology"},{"issue":"7","key":"1300_CR32","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0161-6420(96)30560-5","volume":"103","author":"S Akiya","year":"1996","unstructured":"Akiya S, Nishio Y, Ibi K, Uozumi H, Takahashi H, Hamada T, et al. Lattice corneal dystrophy type II associated with familial amyloid polyneuropathy type IV. Ophthalmology. 1996;103(7):1106\u201310.","journal-title":"Ophthalmology"},{"issue":"4","key":"1300_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1136\/bjo.84.4.390","volume":"84","author":"HS Stewart","year":"2000","unstructured":"Stewart HS, Parveen R, Ridgway AE, Bonshek R, Black GC. Late onset lattice corneal dystrophy with systemic familial amyloidosis, amyloidosis V, in an English family. Br J Ophthalmol. 2000;84(4):390\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"1300_CR34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1755-3768.2009.01686.x","volume":"87","author":"C Carrwik","year":"2009","unstructured":"Carrwik C, Stenevi U. Lattice corneal dystrophy, gelsolin type (Meretoja\u2019s syndrome). Acta Ophthalmol. 2009;87(8):813\u20139.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"1300_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jcrs.2008.07.039","volume":"35","author":"M Papathanassiou","year":"2009","unstructured":"Papathanassiou M, Liarakos VS, Vaikousis E, Paschalidis T, Agrogiannis G, Vergados I. Corneal melt in lattice corneal dystrophy type II after cataract surgery. J Cataract Refract Surg. 2009;35(1):185\u20139.","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"1300_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0022-510X(94)90092-2","volume":"126","author":"S Kiuru","year":"1994","unstructured":"Kiuru S, Matikainen E, Kupari M, Haltia M, Palo J. Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J Neurol Sci. 1994;126(1):40\u20138.","journal-title":"J Neurol Sci"},{"issue":"6","key":"1300_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/14017439709075953","volume":"31","author":"AL Fern\u00e1ndez","year":"1997","unstructured":"Fern\u00e1ndez AL, Herreros JM, Monzonis AM, Panizo A. Heart transplantation for Finnish type familial systemic amyloidosis. Scand Cardiovasc J. 1997;31(6):357\u20139.","journal-title":"Scand Cardiovasc J"},{"issue":"3","key":"1300_CR38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/13506129.2019.1604336","volume":"26","author":"E-K Schmidt","year":"2019","unstructured":"Schmidt E-K, Kiuru-Enari S, Atula S, Tanskanen M. Amyloid in parenchymal organs in gelsolin (AGel) amyloidosis. Amyloid. 2019;26(3):118\u201324.","journal-title":"Amyloid."},{"issue":"suppl_1","key":"1300_CR39","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/europace\/euu300","volume":"17","author":"MP Raatikainen","year":"2015","unstructured":"Raatikainen MP, Arnar DO, Zeppenfeld K, Merino JL, Levya F, Hindriks G, et al. Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association. Ep Europace. 2015;17(suppl_1):i1\u2013i75.","journal-title":"Ep Europace"},{"key":"1300_CR40","first-page":"599","volume":"134","author":"T Kaasalainen","year":"2018","unstructured":"Kaasalainen T, Holmstr\u00f6m M, Kivist\u00f6 S, H\u00e4nninen H, Pakarinen S. Tahdistinpotilaan turvallinen magneettikuvaus on mahdollista. Duodecim. 2018;134:599\u2013602.","journal-title":"Duodecim"},{"key":"1300_CR41","doi-asserted-by":"crossref","unstructured":"Ardalan M, Shoja M, Paunio T. Hereditary gelsolin amyloidosis in Iran 2007: XIth international symposium on amyloidosis. USA: CRC Press; 2007.","DOI":"10.1201\/9781420043358.ch38"},{"issue":"3","key":"1300_CR42","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/0888-7543(92)90183-S","volume":"13","author":"C Maury","year":"1992","unstructured":"Maury C, Kere J, Tolvanen R, De la Chapelle A. Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics. 1992;13(3):902\u20133.","journal-title":"Genomics"},{"issue":"1","key":"1300_CR43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/ndt\/gfl548","volume":"22","author":"MR Ardalan","year":"2007","unstructured":"Ardalan MR, Shoja MM, Kiuru-Enari S. Amyloidosis-related nephrotic syndrome due to a G654A gelsolin mutation: the first report from the Middle East. Nephrol Dial Transplant. 2007;22(1):272\u20135.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1300_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/13506129.2013.764284","volume":"20","author":"P Juusela","year":"2013","unstructured":"Juusela P, Tanskanen M, Nieminen A, Kari K, Suominen L, Uitto V-J, et al. Xerostomia in hereditary gelsolin amyloidosis. Amyloid. 2013;20(1):39\u201344.","journal-title":"Amyloid"},{"issue":"5","key":"1300_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/jech.47.5.355","volume":"47","author":"J Laurikka","year":"1993","unstructured":"Laurikka J, Sisto T, Auvinen O, Tarkka M, L\u00e4\u00e4r\u00e4 E, Hakama M. Varicose veins in a Finnish population aged 40-60. J Epidemiol Community Health. 1993;47(5):355\u20137.","journal-title":"J Epidemiol Community Health"},{"issue":"6","key":"1300_CR46","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1097\/PRS.0b013e318213a0a2","volume":"127","author":"T Pihlamaa","year":"2011","unstructured":"Pihlamaa T, Rautio J, Kiuru-Enari S, Suominen S. Gelsolin amyloidosis as a cause of early aging and progressive bilateral facial paralysis. Plast Reconstr Surg. 2011;127(6):2342\u201351.","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"1300_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/13506129.2016.1238355","volume":"23","author":"T Pihlamaa","year":"2016","unstructured":"Pihlamaa T, Suominen S, Kiuru-Enari S, Tanskanen M. Increasing amount of amyloid are associated with the severity of clinical features in hereditary gelsolin (AGel) amyloidosis. Amyloid. 2016;23(4):225\u201333.","journal-title":"Amyloid"},{"key":"1300_CR48","volume-title":"Effective retirement age in the earnings-related pension scheme [Internet]","author":"Finnish Centre for Pensions","year":"2019","unstructured":"Finnish Centre for Pensions. Effective retirement age in the earnings-related pension scheme [Internet]. 2019 [cited 04.10.2019]. Available from: https:\/\/tilastot.etk.fi\/pxweb\/en\/ETK\/ETK__130elakkeellesiirtymisika\/esiirtymisika01.px\/?rxid=5cc338de-f30e-4199-a522-41039903c359."},{"issue":"12","key":"1300_CR49","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plant\u00e9-Bordeneuve","year":"2011","unstructured":"Plant\u00e9-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011;10(12):1086\u201397.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1300_CR50","doi-asserted-by":"publisher","first-page":"e1000099","DOI":"10.1371\/journal.pgen.1000099","volume":"4","author":"A Palsdottir","year":"2008","unstructured":"Palsdottir A, Helgason A, Palsson S, Bjornsson HT, Bragason BT, Gretarsdottir S, et al. A drastic reduction in the life span of cystatin C L68Q carriers due to life-style changes during the last two centuries. PLoS Genet. 2008;4(6):e1000099.","journal-title":"PLoS Genet"},{"issue":"2","key":"1300_CR51","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1681\/ASN.2008060614","volume":"20","author":"JD Gillmore","year":"2009","unstructured":"Gillmore JD, Lachmann HJ, Rowczenio D, Gilbertson JA, Zeng C-H, Liu Z-H, et al. Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A\u03b1-chain amyloidosis. J Am Soc Nephrol. 2009;20(2):444\u201351.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1300_CR52","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1093\/ndt\/14.11.2639","volume":"14","author":"JD Gillmore","year":"1999","unstructured":"Gillmore JD, Booth DR, Madhoo S, Pepys MB, Hawkins PN. Hereditary renal amyloidosis associated with variant lysozyme in a large English family. Nephrol Dial Transplant. 1999;14(11):2639\u201344.","journal-title":"Nephrol Dial Transplant"},{"key":"1300_CR53","volume-title":"MD: National Cancer Institute, End Results Section. Instructions to IBM 650 programmers in processing survival computations: Methodological note No. 10","author":"F Ederer","year":"1959","unstructured":"Ederer F, Heise HJB. MD: National Cancer Institute, End Results Section. Instructions to IBM 650 programmers in processing survival computations: Methodological note No. 10; 1959."},{"issue":"1","key":"1300_CR54","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/1536867X1501500112","volume":"15","author":"PW Dickman","year":"2015","unstructured":"Dickman PW, Coviello EJTSJ. Estimating and modeling relative survival. Stata J. 2015;15(1):186\u2013215.","journal-title":"Stata J"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1300-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-1300-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1300-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:17:40Z","timestamp":1610756260000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-1300-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1300"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-1300-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"14 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The FIN-GAR phase II study was approved (HUS\/1028\/2018) by the ethical review committee of the Helsinki University Hospital, Helsinki, Finland.The participants gave a written consent before being included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}